Cargando…
Homocysteic Acid in Blood Can Detect Mild Cognitive Impairment: A Preliminary Study
BACKGROUND: In the treatment of Alzheimer’s disease (AD), it is thought to be most effective to intervene at the earliest and mildest stages. For diagnosis at the earliest and mildest stages, it is desirable to use a biomarker that can be detected by a minimally invasive, cost-effective technique. R...
Autores principales: | Hasegawa, Tohru, Kosoku, Yoshinori, Sano, Yuka, Yoshida, Hiroshi, Kudoh, Chiaki, Tabira, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592685/ https://www.ncbi.nlm.nih.gov/pubmed/32741817 http://dx.doi.org/10.3233/JAD-200234 |
Ejemplares similares
-
Targeting therapy for homocysteic acid in the blood represents a potential recovery treatment for cognition in Alzheimer's disease patients
por: Hasegawa, Tohru, et al.
Publicado: (2016) -
Effects of Ferulic Acid and Angelica archangelica Extract (Feru-guard( ®)) on Mild Cognitive Impairment: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Prospective Trial
por: Kudoh, Chiaki, et al.
Publicado: (2020) -
Treatment of Alzheimer's Disease with Anti-Homocysteic Acid Antibody in 3xTg-AD Male Mice
por: Hasegawa, Tohru, et al.
Publicado: (2010) -
Homocyst(e)ine and atherosclerosis in patients on chronic hemodialysis.
por: Lee, Y. K., et al.
Publicado: (1999) -
The Effects of Muscle Mass on Homocyst(e)ine Levels in Plasma and Urine
por: MALINOW, M. RENÉ, et al.
Publicado: (2012)